Rich People Trades
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Rich People Trades

Politics

Trump signs executive order to make healthcare prices ‘transparent’

by admin February 26, 2025
February 26, 2025
Trump signs executive order to make healthcare prices ‘transparent’

President Donald Trump on Tuesday signed an executive order directing the departments of the Treasury, Labor, and Health and Human Services to make healthcare prices transparent.

The order directs the departments to ‘rapidly implement and enforce’ the Trump healthcare price transparency regulations, which he claims were slowed by the Biden administration.

The departments will ensure hospitals and insurers disclose actual prices, not estimates, and take action to make prices comparable across hospitals and insurers, including prescription drug prices.

In addition, they will be required to update their enforcement policies to ensure hospitals and insurers are in compliance with requirements to make prices transparent.

‘When healthcare prices are hidden, large corporate entities like hospitals and insurance companies benefit at the expense of American patients,’ the White House wrote in a statement. ‘Price transparency will lower healthcare prices and help patients and employers get the best deal on healthcare.’

The executive order notes a number of concerns with current healthcare pricing, including that prices vary between hospitals in the same region.

‘One patient in Wisconsin saved $1,095 by shopping for two tests between two hospitals located within 30 minutes of one another,’ according to the statement.

The White House claims one economic analysis found Trump’s original price transparency rules, if fully implemented, could deliver savings of $80 billion for consumers, employers and insurers by 2025.

It added that employers will lower their healthcare costs by an average of 27% on 500 common services by better shopping for care.

‘They’ll be able to check them, compare them, go to different locations, so they can shop for the highest-quality care at the lowest cost,’ Trump wrote in the statement. ‘And this is about high-quality care. You’re also looking at that. You’re looking at comparisons between talents, which is very important. And, then, you’re also looking at cost. And, in some cases, you get the best doctor for the lowest cost. That’s a good thing.’

The White House said American patients are ‘fed up with the status quo,’ with 95% saying healthcare price transparency is an important priority. More than 50% said it should be a top priority of the government.

In his first term, Trump took historic action by mandating that hospitals and insurers make prices public.

A lawsuit was filed against the Biden administration in 2023, alleging it did not enforce the prescription drug transparency requirements. 

‘While the prior Administration failed to prioritize further implementation and enforcement of these requirements, President Trump is delivering on his promises to make the healthcare system more affordable and easier to navigate for patients,’ according to the statement.

Fox News Digital previously reported the administration’s tariffs on China will affect drug costs.

Consumers are more dependent on China for medications for anxiety and other psychiatric disorders, such as antidepressants.

This post appeared first on FOX NEWS

previous post
GOPers press for the release of JFK, Epstein files: Here’s why they’re not out
next post
White House confirms who was appointed as acting administrator of DOGE

Related Posts

Russia fires new hypersonic missile in massive Ukraine...

January 10, 2026

Trump says he could deploy US military in...

October 29, 2025

State Department aware of reports after American tourists...

October 16, 2025

Inside Trump’s first-year power plays and the court...

January 2, 2026

Netanyahu calls on Iranian citizens to seize ‘opportunity’...

June 15, 2025

‘Full-blown battle’ brewing in Dem party as Mamdani-style...

November 26, 2025

Federal judge orders halt to Trump admin’s CFPB...

April 19, 2025

‘He’s back’: Trump’s joint address to Congress to...

March 5, 2025

Scandal leaves International Criminal Court grasping for legitimacy...

December 19, 2025

Turkey’s Erdogan continues crackdown on protesters following arrest...

March 25, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      First lady Melania Trump’s new official portrait revealed

      January 28, 2025
    • 2

      American fighters are dying in Ukraine in growing numbers. Bringing their bodies home is a complex task

      January 30, 2025
    • 3

      ECOWAS pledges to ‘keep door open’ after 3 coup-hit West African nations exit regional bloc

      January 30, 2025
    • 4

      Vale Launches Strategic Review of Thompson Nickel Operations Amid Market Challenges

      January 28, 2025
    • 5

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 6

      Europe’s busiest airport is set to get bigger, as Britain green-lights tortured Heathrow expansion project

      January 30, 2025
    • 7

      DeepSeek is giving the world a window into Chinese censorship and information control

      January 30, 2025
    • Terms and conditions
    • Privacy Policy

    Disclaimer: richpeopletrades.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 richpeopletrades.com | All Rights Reserved